Incidence density of serious infection, opportunistic infection, and tuberculosis associated with biologic treatment in patients with rheumatoid arthritis – a systematic evaluation of the literature
Trung N Tran,1 Herve Caspard,1 Fabio Magrini21Clinical Development, MedImmune, Gaithersburg, MD, USA; 2Eli Lilly, San Diego, CA, USAAbstract: Summary data on the incidence density (ie, incidence per person-year [PY]) of serious infection, opportunistic infection, and tuberculosis associated with eac...
Guardado en:
Autores principales: | Tran TN, Caspard H, Magrini F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a088ba7e8404c779b272fcd2bad8bfd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rheumatoid arthritis: Disease or syndrome?
por: Jessica A Stanich, et al.
Publicado: (2009) -
Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
por: Peter BB Jones, et al.
Publicado: (2010) -
Genetics of rheumatoid arthritis: GWAS and beyond
por: McAllister KM, et al.
Publicado: (2011) -
Update on the use of rituximab for intractable rheumatoid arthritis
por: R John Looney
Publicado: (2009) -
Certolizumab in the long-term treatment of rheumatoid arthritis
por: Scott DL, et al.
Publicado: (2011)